Method and system for controlling a vehicle given to a third party

• US 7,812,712 B2
• Filed: 02/05/2007
• Issued: 10/12/2010
• Est. Priority Date: 02/13/2006
• Status: Expired due to Fees

• Current Assignee: Aspiring Holdings, LLC
• Original Assignee: ALL Protect, LLC
• Inventors: Dorin, Michael, White, Steve, Noto, John
• Primary Examiner(s): TWEEL JR, JOHN ALEXANDER
• Application Number:
  US11/702,795
• Publication Number:
  US 20070200663A1
• Time in Patent Office: 1,345 Days
• Field of Search: 340/426.2, 340/576, 180/272, 180/287, 713/186
• US Class Current: 340/426.2
• CPC Class Codes: A61B 5/145 Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissuemeasuring of blood pressure or blood flow A61B5/02; non-radiation detecting or locating of foreign bodies in blood A61B5/06
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: B60K 28/063 preventing starting of vehicles
• CPC Class Codes: B60R 2325/105 Radio frequency identification data [RFID]
• CPC Class Codes: B60R 2325/205 Mobile phones
• CPC Class Codes: B60R 2325/304 Boats
• CPC Class Codes: B60R 25/04 operating on the propulsion system, e.g. engine or drive motor
• CPC Class Codes: B60R 25/102 a signal being sent to a remote location, e.g. a radio signal being transmitted to a police station, a security company or the owner
• CPC Class Codes: B60R 25/241 whereby access privileges are related to the identifiers
• CPC Class Codes: B60R 25/25 using biometry
• CPC Class Codes: B60R 25/252 Fingerprint recognition
• CPC Class Codes: B60R 25/255 Eye recognition
• CPC Class Codes: B60R 25/257 Voice recognition

Abstract

A method and system for controlling a vehicle given to a third party. The system includes a system controller; a mode-indicating device coupled to the system controller; and an authenticator coupled to the system controller. Here, the system controller is adapted to communicate a driving restriction to the vehicle upon an activation of the mode-indicating device by an authorized driver and until a deactivation of the mode-indicating device by the authorized driver, the system controller is adapted to restrict the activation and the deactivation of the mode-indicating device unless the authorized driver has been authenticated by the authenticator, and the driving restriction includes a limit selected from the group consisting of a limit in number of starts, a limit in speed, a limit in acceleration, a limit in number of minutes, a limit in distance, a limit in gears, a limit in locations, and combinations thereof.

Claims

1. A system for controlling a vehicle given to a third party, the system comprising:

a system controller;

a mode-indicating device coupled to the system controller; and

a biometric authenticator coupled to the system controller, the biometric authenticator adapted to detect at least one biometric parameter at a first dermal location of an operator of the vehicle,

a substance detecting device coupled to the system controller and adapted to provide a substance level to the system controller, the substance detecting device adapted to detect a level of a substance in an operator of the vehicle at a second dermal location proximate to the first dermal location,

wherein the system controller is adapted to communicate a driving restriction to the vehicle upon an activation of the mode-indicating device by an authorized driver, as determined by the biometric authenticator, and until a deactivation of the mode-indicating device by the authorized driver,

wherein the system controller is adapted to restrict the activation of the mode-indicating device unless the authorized driver has been authenticated by the biometric authenticator,

wherein the system controller is adapted to restrict the deactivation of the mode-indicating device unless the authorized driver has been authenticated by the biometric authenticator and the substance level in the authorized driver, as determined by the substance detecting device, is not above a tolerance level, and

wherein the driving restriction comprises a limit selected from the group consisting of a limit in number of starts, a limit in speed, a limit in acceleration, a limit in number of minutes, a limit in distance, a limit in gears, a limit in locations, and combinations thereof.

2. The system of claim 1, wherein the system controller is further adapted to communicate with the vehicle to permit the vehicle to start if the substance level in the third party is not above a tolerance level.

3. The system of claim 2, wherein the system controller is further adapted to communicate another driving restriction to the vehicle if the substance level in the third party is above the tolerance level.

4. The system of claim 3, wherein the driving restriction comprises a command adapted to be sent via a vehicle bus of the vehicle to limit a maximum speed of the vehicle, and wherein the another driving restriction comprises a command adapted to be sent via the vehicle bus of the vehicle to block the vehicle from starting.

5. The system of claim 1, wherein the substance detecting device comprises an optical detector.

6. The system of claim 5, wherein the substance detecting device further comprises a light source configured to direct a first light beam at a specific wavelength band toward the second dermal location,

wherein the optical detector is positioned to detect a resulting light beam from the interaction of the first light beam with the second dermal location.

7. The system of claim 6, wherein the specific wavelength band is within a range from about 1300 nm to about 2400 nm.

8. The system of claim 7, wherein the range is selected from the group consisting of a first range from about 1400 nm to about 1500 nm, a second range from about 1650 nm to about 1750 nm, and a third range from about 2200 nm to about 2400 nm.

9. The system of claim 6, wherein the specific wavelength band is at about 1450 nm.

10. The system of claim 6, wherein the optical detector is selected from the group consisting of a single detector, a plurality of detectors and a detector array.

11. The system of claim 10, wherein the optical detector is an InGaAs detector.

12. The system of claim 1, wherein the substance detecting device comprises an optical detector, a first light beam at a first specific wavelength band directed toward the second dermal location, and a second light beam at a second specific wavelength band directed toward the second dermal location and wherein the optical band detector is positioned to detect a resulting light beam from the interaction of the first light beam and the second light beam with the second dermal location.

13. The system of claim 12, wherein the first specific wavelength band is at a wavelength where ethanol is less absorptive than water and the second specific wavelength band is at a wavelength where ethanol is more absorptive than water.

14. The system of claim 12, wherein the optical detector is selected from the group consisting of a single detector, a plurality of detectors and a detector array.

15. The system of claim 14, wherein the optical detector is an InGaAs detector.

16. The system of claim 12, wherein the first specific wavelength band is within a range from about 1400 nm to about 1500 nm and the second specific wavelength band is within a range from about 1650 nm to about 1750 nm.

17. The system of claim 12, wherein the first specific wavelength band is within a range from about 1400 nm to about 1500 nm and the second specific wavelength band is within a range from about 2200 nm to about 2400 nm.

18. The system of claim 1, wherein the substance detecting device comprises an optical detector, a first light beam at a first specific wavelength band directed toward the second dermal location broadband detector, a second light beam at a second specific wavelength band directed toward the second dermal location, and a third light beam at a third specific wavelength band directed toward the second dermal location and

wherein the optical detector is positioned to detect a resulting light beam from the interaction of the first, second and third light beams with the second dermal location.

19. The system of claim 18, wherein the optical detector is selected from the group consisting of a single detector, a plurality of detectors and a detector array.

20. The system of claim 18, wherein the first specific wavelength band is within a range from about 1400 nm to about 1500 nm, the second specific wavelength band is within a range from about 1650 nm to about 1750 nm, and the third specific wavelength band is within a range from about 2200 nm to about 2400 nm.

21. The system of claim 20, wherein the first specific wavelength band is at about 1450 nm.

22. The system of claim 18, further comprising a light source configured to provide the first, second, and third light beams.

23. The system of claim 22 further comprising a filtering system disposed between the light source and the optical detector and adapted to provide the first, second, and third light beams at the first, second, and third specific wavelength bands.

24. The system of claim 1, wherein the substance detecting device comprises an optical detector selected from the group consisting of a PbS detector, a PbSe detector, an InAs detector, an InGaAs detector, an InSb detector, and a HgCdTe detector and a light source adapted to direct a first light beam at a specific wavelength to the second dermal location, and wherein the optical detector is positioned to detect a resulting light beam from the interaction of the first light beam with the second dermal location.

25. The system of claim 24, further comprising a wavelength filtering system disposed between the light source and the optical detector and adapted to provide the light beam at the specific wavelength band.

26. The system of claim 25, wherein the wavelength filtering system is disposed closer in distance to the optical detector than to the light source.

27. The system of claim 25, further comprising a platform coupled to both the light source and the optical detector, wherein the platform is configured to contact a surface of the extremity of the operator and has an index of refraction substantially equal to that of the surface of extremity of the operator.

28. The system of claim 1, wherein the substance detecting device comprises an optical detector, and a diode laser configured to direct a first light beam at a specific wavelength toward the second dermal location, and wherein the optical detector is positioned to detect a resulting light beam from the interaction of the first light beam with the second dermal location.

29. The system of claim 28, wherein the specific wavelength is at about 1310 nm.

30. The system of claim 29, wherein the optical detector is a single photodiode detector.

31. The system of claim 1, wherein the substance detecting device comprises an optical detector, a first diode laser configured to direct a first light beam at a first specific wavelength toward the second dermal location, and a second diode laser configured to direct a second light beam at a second specific wavelength toward the second dermal location, and wherein the optical detector is positioned to detect a resulting light beam from the interaction of the first and second light beams with the second dermal location.

32. The system of claim 31, wherein the first specific wavelength is at a wavelength where ethanol is less absorptive than water and the second specific wavelength is at a wavelength where ethanol is more absorptive than water.

33. The system of claim 1, wherein the substance detecting device comprises an optical detector, a first diode laser configured to direct a first light beam at a first specific wavelength toward the second dermal location, a second diode laser configured to direct a second light beam at a second specific wavelength toward the second dermal location, and a third diode laser configured to direct a third light beam at a third specific wavelength toward the second dermal location, and wherein the optical detector is positioned to detect a resulting light beam from the interaction of the first, second and third light beams with the second dermal location.

34. The system of claim 1, wherein the driving restriction further comprises another limit selected from the group consisting of a limit in activatable accessories, a limit in openable compartments, and combinations thereof.

35. The system of claim 34, wherein the system controller is further adapted to send a message to a cell phone if the limit has been exceeded to notify a designated individual remotely.

36. The system of claim 35, wherein the system controller is further adapted to create an alert if the limit has been exceeded to notify the authorized driver when the authorized driver retakes control of the vehicle.

37. The system of claim 1, wherein the third party is a valet.

38. The system of claim 1 wherein the substance detecting device comprises a wide band light source and a spectroscopic evaluation device selected from the group consisting of a dispersive spectrometer, a filtering spectrometer, a single or multiple slit monochrometer and a scanning slit monochrometer, to detect the level of a substance in an operator of a vehicle.

39. The system of claim 1 wherein the substance detecting device comprises a single or multiple narrow band light source, and single or multiple optical detectors.